In summary, we identified the CEBPB-Pim-1 signal axis could promote the activation of NLRP3 inflammasome and pyroptosis of glomerular podocytes, which may serve as a therapeutic target against lupus nephritis. Here, NLRP3 is linked to lupus nephritis.